Unknown

Dataset Information

0

Lysine methyltransferase SMYD2 promotes cyst growth in autosomal dominant polycystic kidney disease.


ABSTRACT: Autosomal dominant polycystic kidney disease (ADPKD) is driven by mutations in PKD1 and PKD2 genes. Recent work suggests that epigenetic modulation of gene expression and protein function may play a role in ADPKD pathogenesis. In this study, we identified SMYD2, a SET and MYND domain protein with lysine methyltransferase activity, as a regulator of renal cyst growth. SMYD2 was upregulated in renal epithelial cells and tissues from Pkd1-knockout mice as well as in ADPKD patients. SMYD2 deficiency delayed renal cyst growth in postnatal kidneys from Pkd1 mutant mice. Pkd1 and Smyd2 double-knockout mice lived longer than Pkd1-knockout mice. Targeting SMYD2 with its specific inhibitor, AZ505, delayed cyst growth in both early- and later-stage Pkd1 conditional knockout mouse models. SMYD2 carried out its function via methylation and activation of STAT3 and the p65 subunit of NF-?B, leading to increased cystic renal epithelial cell proliferation and survival. We further identified two positive feedback loops that integrate epigenetic regulation and renal inflammation in cyst development: SMYD2/IL-6/STAT3/SMYD2 and SMYD2/TNF-?/NF-?B/SMYD2. These pathways provide mechanisms by which SMYD2 might be induced by cyst fluid IL-6 and TNF-? in ADPKD kidneys. The SMYD2 transcriptional target gene Ptpn13 also linked SMYD2 to other PKD-associated signaling pathways, including ERK, mTOR, and Akt signaling, via PTPN13-mediated phosphorylation.

SUBMITTER: Li LX 

PROVIDER: S-EPMC5490754 | biostudies-literature | 2017 Jun

REPOSITORIES: biostudies-literature

altmetric image

Publications

Lysine methyltransferase SMYD2 promotes cyst growth in autosomal dominant polycystic kidney disease.

Li Linda Xiaoyan LX   Fan Lucy X LX   Zhou Julie Xia JX   Grantham Jared J JJ   Calvet James P JP   Sage Julien J   Li Xiaogang X  

The Journal of clinical investigation 20170612 7


Autosomal dominant polycystic kidney disease (ADPKD) is driven by mutations in PKD1 and PKD2 genes. Recent work suggests that epigenetic modulation of gene expression and protein function may play a role in ADPKD pathogenesis. In this study, we identified SMYD2, a SET and MYND domain protein with lysine methyltransferase activity, as a regulator of renal cyst growth. SMYD2 was upregulated in renal epithelial cells and tissues from Pkd1-knockout mice as well as in ADPKD patients. SMYD2 deficiency  ...[more]

Similar Datasets

| S-EPMC10968819 | biostudies-literature
2024-06-11 | GSE257535 | GEO
| S-EPMC6171277 | biostudies-literature
| S-EPMC6556721 | biostudies-literature
| S-EPMC3643310 | biostudies-literature
| S-EPMC3758452 | biostudies-literature
| S-EPMC8455272 | biostudies-literature
| S-EPMC2880522 | biostudies-literature
| S-EPMC6065086 | biostudies-literature
| S-EPMC4101988 | biostudies-literature